MCID: ATR005
MIFTS: 51

Atrophic Gastritis

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Atrophic Gastritis

MalaCards integrated aliases for Atrophic Gastritis:

Name: Atrophic Gastritis 12 14
Gastritis, Atrophic 41 69
Gastritis Atrophic 51
Gastric Atrophy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8929
ICD10 32 K29.4
ICD9CM 34 535.1 535.11
MeSH 41 D005757
NCIt 46 C7405

Summaries for Atrophic Gastritis

MalaCards based summary : Atrophic Gastritis, also known as gastritis, atrophic, is related to autoimmune atrophic gastritis and gastric ulcer, and has symptoms including dyspepsia An important gene associated with Atrophic Gastritis is CHGA (Chromogranin A), and among its related pathways/superpathways are IL-17 Family Signaling Pathways and Toll Comparative Pathway. The drugs Hydroxocobalamin and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include testes, thyroid and spleen.

Wikipedia : 72 Atrophic gastritis (also known as Type A or Type B Gastritis more specifically) is a process of chronic... more...

Related Diseases for Atrophic Gastritis

Diseases in the Atrophic Gastritis family:

Autoimmune Atrophic Gastritis

Diseases related to Atrophic Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 197)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.5 CHGA GAST
2 gastric ulcer 30.6 CXCL8 GAST IL1B IL1RN
3 esophagitis 30.6 CXCL8 IL1B TP53
4 helicobacter pylori infection 30.4 CXCL8 GAST IL1B IL1RN S100A8 TNF
5 gastric neuroendocrine neoplasm 30.4 CHGA GAST
6 gastric cancer 30.0 CDX2 GAST IL1RN S100A8 TP53
7 microinvasive gastric cancer 29.9 CDX2 GAST S100A8
8 arthritis 29.8 CXCL8 IL1B IL1RN TNF
9 dyspepsia 29.6 CXCL8 GHRL PGC
10 duodenal ulcer 29.6 CXCL8 GAST IL1B IL1RN S100A8 TNF
11 gastric adenocarcinoma 29.5 CDX2 CHGA GAST IL1RN S100A8
12 gastroesophageal reflux 29.5 CDX2 CXCL8 GHRL IL1B TP53
13 gastritis 27.8 ADH7 CDX2 CHGA CXCL8 GAST GHRL
14 megaloblastic anemia 1 10.9
15 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.6
16 polyposis, gastric 10.5 IL1B TNF
17 recurrent corneal erosion 10.5 CXCL8 IL1B
18 gastrointestinal neuroendocrine benign tumor 10.5 CHGA GAST
19 systemic onset juvenile idiopathic arthritis 10.5 IL1B TNF
20 bagassosis 10.5 CXCL8 IL1B
21 staphylococcal toxic shock syndrome 10.4 IL1B TNF
22 kashin-beck disease 10.4 IL1B TNF
23 pernicious anemia 10.4
24 tungiasis 10.4 CXCL8 TNF
25 pouchitis 10.4 CXCL8 IL1RN
26 goblet cell carcinoid 10.4 CHGA GAST
27 gastric cancer, hereditary diffuse 10.4 IL1B IL1RN
28 streptococcal toxic-shock syndrome 10.4 CXCL8 TNF
29 vaginal benign neoplasm 10.4 CDX2 CHGA
30 pylorospasm 10.4 GAST GHRL
31 vaginal adenoma 10.4 CDX2 CHGA
32 vaginal tubulovillous adenoma 10.4 CDX2 CHGA
33 scleral disease 10.4 IL1RN TNF
34 vulvar vestibulitis syndrome 10.3 IL1B IL1RN TNF
35 peptic esophagitis 10.3 CXCL8 IL1B
36 osteosclerotic myeloma 10.3 IL1B IL1RN TNF
37 burns 10.3 IL1B TNF
38 schnitzler syndrome 10.3 IL1B IL1RN
39 joint disorders 10.3 IL1B IL1RN TNF
40 adult-onset still's disease 10.3 IL1B IL1RN TNF
41 aphthous stomatitis 10.3 IL1B IL1RN TNF
42 haemophilus influenzae 10.3 CXCL8 IL1B TNF
43 dengue shock syndrome 10.3 IL1B IL1RN TNF
44 crohn's colitis 10.3 CXCL8 IL1B TNF
45 dental pulp disease 10.3 CXCL8 IL1B TNF
46 aging 10.3
47 idiopathic neutropenia 10.3 IL1B IL1RN TNF
48 pulpitis 10.3 CXCL8 IL1B TNF
49 middle ear disease 10.3 CXCL8 IL1B TNF
50 viral encephalitis 10.3 CXCL8 IL1B TNF

Comorbidity relations with Atrophic Gastritis via Phenotypic Disease Network (PDN): (show all 18)


Active Peptic Ulcer Disease Acute Cystitis
Acute Pancreatitis Anxiety
Bronchitis Chronic Myocardial Ischemia
Deficiency Anemia Duodenitis
Dysthymic Disorder Esophagitis
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Iron Deficiency Anemia
Irritable Bowel Syndrome Ischemic Heart Disease
Paralytic Ileus Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Atrophic Gastritis:



Diseases related to Atrophic Gastritis

Symptoms & Phenotypes for Atrophic Gastritis

UMLS symptoms related to Atrophic Gastritis:


dyspepsia

Drugs & Therapeutics for Atrophic Gastritis

Drugs for Atrophic Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 104)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydroxocobalamin Approved Phase 4 13422-51-0 5460373 44475014 11953898
2
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
3
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
4
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
5
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
6
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
7
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
8
Metronidazole Approved Phase 4,Phase 3 443-48-1 4173
9
Moxifloxacin Approved, Investigational Phase 4 151096-09-2, 354812-41-2 152946
10
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7 9579578 4594
11
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
12
Pectin Approved, Vet_approved Phase 4 9000-69-5 441476
13
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
14
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
15
Methylcobalamin Approved, Experimental, Investigational, Nutraceutical Phase 4 13422-55-4
16 Micronutrients Phase 4
17 Trace Elements Phase 4
18 Hematinics Phase 4
19 Vitamin B 12 Phase 4
20 Vitamin B Complex Phase 4
21 Vitamins Phase 4,Phase 3
22 Proton pump inhibitors Phase 4,Phase 3
23
Bismuth Phase 4 7440-69-9 105143 16682734
24 Estradiol valerate Phase 4 979-32-8
25 Fluoroquinolones Phase 4
26 Gastrointestinal Agents Phase 4,Phase 3
27 Topoisomerase Inhibitors Phase 4
28 Contraceptive Agents Phase 4
29 Contraceptives, Oral Phase 4
30 Contraceptives, Oral, Combined Phase 4
31 Norgestimate, ethinyl estradiol drug combination Phase 4
32 Nucleic Acid Synthesis Inhibitors Phase 4
33 Antacids Phase 4,Phase 3
34 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
35 Estradiol 17 beta-cypionate Phase 4
36 Estradiol 3-benzoate Phase 4
37 Anti-Infective Agents Phase 4,Phase 3,Phase 2
38 Polyestradiol phosphate Phase 4
39 Anti-Ulcer Agents Phase 4,Phase 3
40 Liposomal amphotericin B Phase 4
41 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
42 Antiparasitic Agents Phase 4,Phase 3,Phase 2
43 Folate Nutraceutical Phase 4
44 Vitamin B12 Nutraceutical Phase 4
45
Cobalamin Nutraceutical Phase 4 13408-78-1 6438156
46 Vitamin B9 Nutraceutical Phase 4
47
Omeprazole Approved, Investigational, Vet_approved Phase 3,Phase 2 73590-58-6 4594
48
Selenium Approved, Investigational, Vet_approved Phase 3 7782-49-2
49
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
50
Vitamin C Approved, Nutraceutical Phase 3 50-81-7 54670067 5785

Interventional clinical trials:

(show all 47)

# Name Status NCT ID Phase Drugs
1 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
2 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
3 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
4 Difference of Gastric Microbiota in the Process of Correa's Model. Recruiting NCT02833363 Phase 4
5 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
6 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
7 Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia Completed NCT00719420 Phase 3 Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);Clarithromycin, Amoxicillin, Omeprazole
8 A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province Completed NCT00339768 Phase 3 Amoxicillin/omeprazole
9 A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach Completed NCT01132534 Phase 3
10 L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde Completed NCT02524262 Phase 2
11 Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer Completed NCT01002443 Phase 2 Helicobacter pylori eradication;placebo
12 Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Recruiting NCT02782949 Phase 2 Curcumin
13 Chemoprevention of Gastric Carcinogenesis Recruiting NCT02794428 Phase 2 Eflornithine
14 YF476 and Type I Gastric Carcinoids Active, not recruiting NCT01339169 Phase 2 YF476
15 YF476 and Type I Gastric Carcinoids (Norway) Terminated NCT01444014 Phase 2 YF476
16 Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study Unknown status NCT02675010
17 HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome Unknown status NCT01931293
18 Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy Unknown status NCT02126722
19 Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus Unknown status NCT00155805
20 Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome Unknown status NCT02695186
21 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Unknown status NCT01813994 Arm1: Statin;Arm2: Placebo
22 Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy Unknown status NCT02284802
23 Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway Unknown status NCT00498134 Triple therapy for H. pylori infection;Cox-2 inhibitor
24 Volatile Markers in Digestive Cancer Unknown status NCT02332213
25 Grading Atrophic Gastritis by Confocal Laser Endomicroscopy Probe (p-CLE) Completed NCT02351154
26 Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years Completed NCT01824953
27 Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy Completed NCT02724280
28 New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy Completed NCT02597517
29 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
30 Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis Completed NCT00920712 Weiqi decotion
31 Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) Completed NCT00212225
32 Gastric Microbiota and Helicobacter Pylori Test Findings Completed NCT02542579
33 New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy Completed NCT01896310
34 Performances of a Fast Test for the Detection of Helicobacter Pylori Antigens in Child Stool Completed NCT03324763
35 Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients Recruiting NCT02691637
36 Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation Recruiting NCT03314038
37 Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea Recruiting NCT02184910 pepsinogen and gastrin
38 Gastropanel for Gastric Atrophy and Cancer Risk Assessment Recruiting NCT02114411
39 Gastric Cancer Screening Quality Improvement System Establishment Recruiting NCT02457624
40 OLGA and OLGIM Stage System for Gastric Cancer Recruiting NCT03380052
41 Surveillance of Patients With Precancerous Lesions of the Stomach Recruiting NCT03250091
42 Optimal Site for Rapid Urease Test in the Stomach Recruiting NCT02945137
43 Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation Not yet recruiting NCT03261934
44 The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis Not yet recruiting NCT02955134 Talcid®;Chinese medicine prescription;Placebo;Compound Azimtamide Entieric-coated Tablets
45 System Biology of Spleen Deficiency Syndrome Not yet recruiting NCT02915393
46 Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk Not yet recruiting NCT02624271
47 Volatiles in Breath and Headspace Analysis - Diagnostic Markers Not yet recruiting NCT03228095

Search NIH Clinical Center for Atrophic Gastritis

Cochrane evidence based reviews: gastritis, atrophic

Genetic Tests for Atrophic Gastritis

Anatomical Context for Atrophic Gastritis

MalaCards organs/tissues related to Atrophic Gastritis:

38
Testes, Thyroid, Spleen, Liver, Colon, T Cells, Endothelial

Publications for Atrophic Gastritis

Articles related to Atrophic Gastritis:

(show top 50) (show all 628)
# Title Authors Year
1
Symptomatic Non-acidic Reflux in a Patient With Chronic Autoimmune Atrophic Gastritis Successfully Treated With Anti-reflux Surgery. ( 29291616 )
2018
2
Impact of SNP-SNP interactions of DNA repair gene<i>ERCC5</i>and metabolic gene<i>GSTP1</i>on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
3
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
4
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. ( 29193217 )
2018
5
NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis. ( 27697573 )
2017
6
Gastric neuroendocrine tumor with hypergastrinemia following type B chronic atrophic gastritis: a case report. ( 28163290 )
2017
7
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis-Authors' reply. ( 29105133 )
2017
8
CHINESE HERBAL DECOCTION AS A COMPLEMENTARY THERAPY FOR ATROPHIC GASTRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. ( 28638893 )
2017
9
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. ( 27806647 )
2017
10
The challenging diagnosis of autoimmune atrophic gastritis. ( 28040990 )
2017
11
Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach? ( 29138645 )
2017
12
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer. ( 28465717 )
2017
13
An Atypical Presentation of Chronic Atrophic Gastritis: Hemolytic Anemia and Mesenteric Panniculitis. ( 28758037 )
2017
14
Autoimmune atrophic gastritis: current perspectives. ( 28223833 )
2017
15
Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection. ( 28918609 )
2017
16
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. ( 28487082 )
2017
17
Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis. ( 28405320 )
2017
18
Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies. ( 28816977 )
2017
19
Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis. ( 28337217 )
2017
20
The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. ( 28738092 )
2017
21
Long non-coding RNA polymorphisms in 6p21.1 are associated with atrophic gastritis risk and gastric cancer prognosis. ( 29221129 )
2017
22
Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50A years: A cross-sectional study. ( 29034535 )
2017
23
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. ( 29095917 )
2017
24
NMR-based metabolomics Reveals Alterations of Electro-acupuncture Stimulations on Chronic Atrophic Gastritis Rats. ( 28358020 )
2017
25
Severe upper gastrointestinal bleeding determined by a gastric lymphoma associated with Helicobacter pylori-positive atrophic gastritis. ( 28730251 )
2017
26
The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. ( 28728545 )
2017
27
Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG). ( 29084954 )
2017
28
Editorial: the non-invasive diagnosis of atrophic gastritis. ( 29105139 )
2017
29
The relationship of interpersonal sensitivity and depression among patients with chronic atrophic gastritis: The mediating role of coping styles. ( 29052273 )
2017
30
Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk. ( 28562347 )
2017
31
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis. ( 29105138 )
2017
32
Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. ( 28662697 )
2017
33
Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. ( 28782119 )
2017
34
Atrophic Gastritis Increases the Risk of Gastric Cancer in Asymptomatic Population in Korea. ( 28874038 )
2017
35
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. ( 28049442 )
2017
36
Associations of Helicobacter pylori infection and chronic atrophic gastritis with accelerated epigenetic ageing in older adults. ( 28898235 )
2017
37
High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia. ( 28341758 )
2017
38
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. ( 26928404 )
2016
39
Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks. ( 26760766 )
2016
40
Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia? ( 27250981 )
2016
41
A Panel of Serum Biomarkers (GastroPanelAr) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis. ( 27798873 )
2016
42
An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients. ( 27196446 )
2016
43
Exploratory Factor Analysis for Validating Traditional Chinese Syndrome Patterns of Chronic Atrophic Gastritis. ( 28077948 )
2016
44
Clinical and Endoscopic Features of Undifferentiated Gastric Cancer in Patients with Severe Atrophic Gastritis. ( 27086796 )
2016
45
An Unusual Presentation of Pseudothrombotic Microangiopathy in a Patient with Autoimmune Atrophic Gastritis. ( 27018160 )
2016
46
Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country. ( 28034664 )
2016
47
Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: a nested case-control study. ( 28032715 )
2016
48
Cytokine-producing function of human blood cells in chronic atrophic gastritis and gastric adenomas and adenocarcinomas. ( 27193885 )
2016
49
Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. ( 26839577 )
2016
50
The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. ( 27149493 )
2016

Variations for Atrophic Gastritis

Expression for Atrophic Gastritis

Search GEO for disease gene expression data for Atrophic Gastritis.

Pathways for Atrophic Gastritis

Pathways related to Atrophic Gastritis according to GeneCards Suite gene sharing:

(show all 20)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.14 CXCL8 IL1B S100A8 TNF
2
Show member pathways
12 CXCL8 IL1B TNF TP53
3 11.88 CXCL8 IL1B IL1RN TNF
4 11.78 CXCL8 IL1B TP53
5 11.74 CXCL8 IL1B TNF
6 11.72 CXCL8 IL1B TNF
7 11.7 CXCL8 IL1B TNF
8 11.67 CXCL8 IL1B TNF
9 11.58 CXCL8 IL1B TNF
10 11.54 CXCL8 IL1B TNF TP53
11 11.47 CXCL8 IL1B TNF
12
Show member pathways
11.45 CXCL8 IL1B TNF
13 11.37 CXCL8 IL1B TNF
14 11.31 CXCL8 IL1B TNF TP53
15 11.3 CXCL8 IL1B TNF
16 11.15 CDX2 IL1B TNF
17
Show member pathways
11.07 PGA3 PGA4 PGA5
18 10.87 CXCL8 TNF
19 10.79 IL1B TNF
20 10.61 CXCL8 IL1B IL1RN TNF

GO Terms for Atrophic Gastritis

Cellular components related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.81 CHGA CXCL8 GAST GHRL IL1B IL1RN
2 extracellular region GO:0005576 9.44 ADH7 CHGA CXCL8 GAST GHRL IL1B
3 multivesicular body lumen GO:0097486 9.13 PGA3 PGA4 PGA5

Biological processes related to Atrophic Gastritis according to GeneCards Suite gene sharing:

(show all 20)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.8 CXCL8 IL1B IL1RN S100A8 TNF
2 response to ethanol GO:0045471 9.74 ADH7 S100A8 TP53
3 activation of MAPK activity GO:0000187 9.73 GHRL IL1B TNF
4 regulation of receptor activity GO:0010469 9.73 CXCL8 GAST GHRL IL1B IL1RN TNF
5 neutrophil chemotaxis GO:0030593 9.67 CXCL8 IL1B S100A8
6 embryonic digestive tract development GO:0048566 9.59 CXCL8 TNF
7 positive regulation of protein export from nucleus GO:0046827 9.58 IL1B TP53
8 negative regulation of lipid catabolic process GO:0050995 9.58 IL1B TNF
9 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.55 IL1B TNF
10 regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122 9.54 IL1B TNF
11 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.52 IL1B TNF
12 positive regulation of chemokine biosynthetic process GO:0045080 9.51 IL1B TNF
13 regulation of establishment of endothelial barrier GO:1903140 9.48 IL1B TNF
14 fever generation GO:0001660 9.46 IL1B IL1RN
15 digestion GO:0007586 9.46 PGA3 PGA4 PGA5 PGC
16 positive regulation of fever generation GO:0031622 9.43 IL1B TNF
17 sequestering of triglyceride GO:0030730 9.37 IL1B TNF
18 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.32 IL1B TNF
19 protein catabolic process GO:0030163 9.26 PGA3 PGA4 PGA5 PGC
20 autophagy GO:0006914 9.1 PGA3 PGA4 PGA5 PGC S100A8 TP53

Molecular functions related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 CXCL8 IL1B IL1RN TNF
2 interleukin-1 receptor binding GO:0005149 9.16 IL1B IL1RN
3 aspartic-type endopeptidase activity GO:0004190 8.92 PGA3 PGA4 PGA5 PGC

Sources for Atrophic Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....